Mr Paul Ranson > Morgan, Lewis & Bockius UK LLP > London, England > Lawyer Profile
Morgan, Lewis & Bockius UK LLP Offices
CONDOR HOUSE
5-10 ST PAUL'S CHURCHYARD
LONDON
EC4M 8AL
England
- Firm Profile
- Go to...
Mr Paul Ranson
Work Department
Life Sciences
Position
Paul Ranson is a consultant who focuses on the regulatory and commercial needs of the pharmaceutical, biotechnology, and medical devices sectors. Paul’s regulatory expertise covers both marketing authorisation-related matters and market access, pricing, and reimbursement issues. His commercial work is concentrated on transactions with a high degree of industry specificity including collaborations and outsourcing transactions. For more information, view Paul’s biography at www.morganlewis.com/bios/pranson.
Education
University of Nottingham, England, 1975, LLB, Law
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
Transactional, regulatory and competition work are three key strata running through the life sciences offering at Morgan, Lewis & Bockius UK LLP. Allison Soilihi co-heads the team and is well-placed to handle corporate life sciences work such as private equity transactions. Merger clearances and licensing mandates are firmly in the wheelhouse of fellow co-head Omar Shah. Paul Ranson‘s practice straddles commercial and regulatory matters, while Frances Murphy 
is an authority on EU and UK competition matters.
Lawyer Rankings
Top Tier Firm Rankings
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
Firm Rankings
- Industry focus > Emerging markets
- Transport > Aviation
- Dispute resolution > Competition litigation
- Finance > Debt capital markets
- Employment > Employers
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Projects, energy and natural resources > Oil and gas
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Securitisation
- Corporate and commercial > Financial services: contentious
- Employment > Immigration
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Dispute resolution > Banking litigation: investment and retail
- Corporate and commercial > Corporate tax
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Investment fund formation and management > Private funds
- Finance > Transport finance and leasing
- Dispute resolution > Commercial litigation: premium
- Risk advisory > Data protection, privacy and cybersecurity
- Projects, energy and natural resources > Renewables